379 related articles for article (PubMed ID: 16818210)
1. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
Tester DJ; Arya P; Will M; Haglund CM; Farley AL; Makielski JC; Ackerman MJ
Heart Rhythm; 2006 Jul; 3(7):800-5. PubMed ID: 16818210
[TBL] [Abstract][Full Text] [Related]
2. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
Tester DJ; Kopplin LJ; Will ML; Ackerman MJ
Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589
[TBL] [Abstract][Full Text] [Related]
3. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Medeiros-Domingo A; Bhuiyan ZA; Tester DJ; Hofman N; Bikker H; van Tintelen JP; Mannens MM; Wilde AA; Ackerman MJ
J Am Coll Cardiol; 2009 Nov; 54(22):2065-74. PubMed ID: 19926015
[TBL] [Abstract][Full Text] [Related]
4. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes.
Choi G; Kopplin LJ; Tester DJ; Will ML; Haglund CM; Ackerman MJ
Circulation; 2004 Oct; 110(15):2119-24. PubMed ID: 15466642
[TBL] [Abstract][Full Text] [Related]
5. Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects.
Sherman J; Tester DJ; Ackerman MJ
Heart Rhythm; 2005 Nov; 2(11):1218-23. PubMed ID: 16253912
[TBL] [Abstract][Full Text] [Related]
6. The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.
Roston TM; Yuchi Z; Kannankeril PJ; Hathaway J; Vinocur JM; Etheridge SP; Potts JE; Maginot KR; Salerno JC; Cohen MI; Hamilton RM; Pflaumer A; Mohammed S; Kimlicka L; Kanter RJ; LaPage MJ; Collins KK; Gebauer RA; Temple JD; Batra AS; Erickson C; Miszczak-Knecht M; Kubuš P; Bar-Cohen Y; Kantoch M; Thomas VC; Hessling G; Anderson C; Young ML; Choi SHJ; Cabrera Ortega M; Lau YR; Johnsrude CL; Fournier A; Van Petegem F; Sanatani S
Europace; 2018 Mar; 20(3):541-547. PubMed ID: 28158428
[TBL] [Abstract][Full Text] [Related]
7. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases.
Tester DJ; Spoon DB; Valdivia HH; Makielski JC; Ackerman MJ
Mayo Clin Proc; 2004 Nov; 79(11):1380-4. PubMed ID: 15544015
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of unexplained drowning: new insights from a molecular autopsy.
Tester DJ; Kopplin LJ; Creighton W; Burke AP; Ackerman MJ
Mayo Clin Proc; 2005 May; 80(5):596-600. PubMed ID: 15887426
[TBL] [Abstract][Full Text] [Related]
9. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
[TBL] [Abstract][Full Text] [Related]
10. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
Tester DJ; Will ML; Haglund CM; Ackerman MJ
Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
[TBL] [Abstract][Full Text] [Related]
11. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
Katz G; Arad M; Eldar M
Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
[TBL] [Abstract][Full Text] [Related]
12. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.
Tester DJ; Dura M; Carturan E; Reiken S; Wronska A; Marks AR; Ackerman MJ
Heart Rhythm; 2007 Jun; 4(6):733-9. PubMed ID: 17556193
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
Laitinen PJ; Swan H; Kontula K
Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of familial CPVT after 30 years.
Beery TA; Shah MJ; Benson DW
Biol Res Nurs; 2009 Jul; 11(1):66-72. PubMed ID: 19398417
[TBL] [Abstract][Full Text] [Related]
16. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O
J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920
[TBL] [Abstract][Full Text] [Related]
17. Linking the heart and the brain: Neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia.
Lieve KVV; Verhagen JMA; Wei J; Bos JM; van der Werf C; Rosés I Noguer F; Mancini GMS; Guo W; Wang R; van den Heuvel F; Frohn-Mulder IME; Shimizu W; Nogami A; Horigome H; Roberts JD; Leenhardt A; Crijns HJG; Blank AC; Aiba T; Wiesfeld ACP; Blom NA; Sumitomo N; Till J; Ackerman MJ; Chen SRW; van de Laar IMBH; Wilde AAM
Heart Rhythm; 2019 Feb; 16(2):220-228. PubMed ID: 30170228
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
[TBL] [Abstract][Full Text] [Related]
19. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
[TBL] [Abstract][Full Text] [Related]
20. Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results.
Tester DJ; Cronk LB; Carr JL; Schulz V; Salisbury BA; Judson RS; Ackerman MJ
Heart Rhythm; 2006 Jul; 3(7):815-21. PubMed ID: 16818214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
